Liposomal vs conventional irinotecan: safety profiles compared

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92738-3

Cited by: 0

References: 1

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Cancer therapeutics and mechanisms Pharmacovigilance and Adverse Drug Reactions

References 1